🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screenerTry Stock Screener

Vyne Therapeutics Inc (VYNE)

NASDAQ
Currency in USD
3.280
+0.290(+9.70%)
Closed
After Hours
3.250-0.030(-0.915%)
VYNE Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
2.9603.300
52 wk Range
1.5704.481
Prev. Close
3.28
Open
3.01
Day's Range
2.96-3.3
52 wk Range
1.57-4.481
Volume
193,118
Average Volume (3m)
65,007
1-Year Change
0.61%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
VYNE Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
5.583
Upside
+70.213%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Vyne Therapeutics Company Profile

VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary and therapeutics for the treatment of immuno-inflammatory conditions. The company’s lead product is VYN201, a locally administered pan- bromodomain and extra-terminal (BET) inhibitor soft drug to address diseases involving multiple, diverse inflammatory cell signaling pathways with low systemic exposure. It also develops VYN202, a BD2-selective oral small molecule BET inhibitor for the treatment of immuno-inflammatory indications. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.

Compare VYNE to Peers and Sector

Metrics to compare
VYNE
Peers
Sector
Relationship
P/E Ratio
−1.7x−2.1x−0.6x
PEG Ratio
−0.02−0.010.00
Price/Book
0.6x1.4x2.6x
Price / LTM Sales
99.5x2.6x3.2x
Upside (Analyst Target)
92.3%138.1%46.3%
Fair Value Upside
Unlock19.9%6.1%Unlock

FAQ

What Is the Vyne Therapeutics (VYNE) Stock Price Today?

The Vyne Therapeutics stock price today is 3.28.

What Stock Exchange Does Vyne Therapeutics Trade On?

Vyne Therapeutics is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Vyne Therapeutics?

The stock symbol for Vyne Therapeutics is "VYNE."

What Is the Vyne Therapeutics Market Cap?

As of today, Vyne Therapeutics market cap is 48.38M.

What is Vyne Therapeutics Earnings Per Share?

The Vyne Therapeutics EPS is -0.955.

From a Technical Analysis Perspective, Is VYNE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.